Literature DB >> 21492713

Insights on the revascularization mechanism for treatment of Moyamoya disease based on the histopathologic concept of angiogenesis and arteriogenesis.

Nobuhito Saito1, Hideaki Imai.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21492713     DOI： 10.1016/j.wneu.2010.10.004

Source DB:  PubMed          Journal:  World Neurosurg        ISSN： 1878-8750            Impact factor:   2.104


× No keyword cloud information.
  6 in total

1.  Clinical and angiographic outcomes after combined direct and indirect bypass in adult patients with moyamoya disease: A retrospective study of 76 procedures.

Authors:  Jinbing Zhao; Hongyi Liu; Yuanjie Zou; Wenbin Zhang; Shengxue He
Journal:  Exp Ther Med       Date:  2018-02-07       Impact factor: 2.447

2.  Angiographic Structural Differentiation between Native Arteriogenesis and Therapeutic Synangiosis in Intracranial Arterial Steno-Occlusive Disease.

Authors:  Y C Ooi; A N Laiwalla; R Liou; N R Gonzalez
Journal:  AJNR Am J Neuroradiol       Date:  2016-01-21       Impact factor: 3.825

3.  Endothelial Progenitor Cells Induce Angiogenesis: a Potential Mechanism Underlying Neovascularization in Encephaloduroarteriosynangiosis.

Authors:  Qian-Nan Wang; Zheng-Xing Zou; Xiao-Peng Wang; Qian Zhang; Ya-Qun Zhao; Lian Duan; Xiang-Yang Bao
Journal:  Transl Stroke Res       Date:  2020-07-06       Impact factor: 6.829

4.  Steroids and Immunosuppressant Agents Do Not Affect Indirect Revascularization in Quasi-Moyamoya Disease Associated with Pure Red Cell Aplasia: A Case Report.

Authors:  Naoya Kidani; Toshikazu Kimura; Yasumitsu Ichikawa; Kensuke Usuki; Akio Morita
Journal:  NMC Case Rep J       Date:  2014-12-06

5.  The Potential Mechanism Behind Native and Therapeutic Collaterals in Moyamoya.

Authors:  Xiang-Yang Bao; Yan-Na Fan; Qian-Nan Wang; Xiao-Peng Wang; Ri-Miao Yang; Zheng-Xing Zou; Qian Zhang; De-Sheng Li; Lian Duan; Xin-Guang Yu
Journal:  Front Neurol       Date:  2022-04-26       Impact factor: 4.003

6.  Expression of circulating vascular endothelial growth factor-antagonizing cytokines and vascular stabilizing factors prior to and following bypass surgery in patients with moyamoya disease.

Authors:  Jin He; Rong Wang; Dong Zhang; Yan Zhang; Qian Zhang; Jizong Zhao
Journal:  Exp Ther Med       Date:  2014-05-14       Impact factor: 2.447
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.